A Florida court has upheld a ruling against Agios Corp St. Mary Pharmacy and Compounding and Medical Supplies. The District Court of Appeal of Florida decided on September 1, 2026, to affirm a previous decision made by the Department of Business and Professional Regulation. This ruling affects compounding pharmacies across the state and highlights the regulatory environment for such businesses.
The case, identified by docket number 5D2025-3501, centers on the actions of Agios Corp St. Mary Pharmacy and its compliance with state regulations. The court's decision is significant as it reinforces the authority of the Department of Business and Professional Regulation in overseeing pharmacy operations.
Agios Corp St. Mary Pharmacy is a compounding pharmacy that specializes in preparing customized medications for patients. The pharmacy's operations came under scrutiny, leading to an administrative appeal against the Department of Business and Professional Regulation, which oversees drugs, devices, and cosmetics in Florida. The dispute arose from concerns regarding the pharmacy's compliance with state regulations governing the compounding of medications.
The case was brought to the District Court of Appeal after Agios Corp St. Mary Pharmacy sought to challenge the Department's ruling. The appeal was handled by Veronica Bayó Clifford and Edwin A. Bayó from the law firm Grossman, Roopnarine & Bayo, LLC, while the Department of Business and Professional Regulation was represented by Chief Appellate Counsel Matthew Mears and General Counsel Andrew Fier.
In its ruling, the court affirmed the lower court's decision without providing detailed reasoning in the opinion. The judges involved in this case were Chief Judge Jay and Judges Eisnaugle and Soud, who all concurred with the decision. The court stated simply, "AFFIRMED," indicating that the previous ruling stands as is.
The affirmation of the ruling means that Agios Corp St. Mary Pharmacy must continue to comply with the regulations set forth by the Department of Business and Professional Regulation. This decision underscores the importance of regulatory compliance for pharmacies, particularly those involved in compounding medications, which can have significant implications for patient safety and public health.
This ruling may set a precedent for how similar cases are handled in the future, particularly those involving compounding pharmacies. It highlights the need for these businesses to adhere strictly to state regulations to avoid penalties or legal challenges. The decision also serves as a reminder to other pharmacies about the importance of compliance with regulatory standards.
Looking ahead, it is unclear whether Agios Corp St. Mary Pharmacy will seek to appeal this ruling further. The court's decision is not final until any timely and authorized motions are resolved under Florida Rule of Appellate Procedure 9.330 or 9.331. This means that the pharmacy could potentially challenge the ruling again if it finds grounds for further appeal.
Details were not available in the court filing regarding any specific violations or issues that led to the initial ruling against Agios Corp St. Mary Pharmacy. However, the case highlights the ongoing scrutiny and regulatory challenges that compounding pharmacies face in Florida and across the United States.